SARS-CoV2 Infection
Conditions
Keywords
Fatigue, Covid-19 Disease
Brief summary
Prospective, controlled follow-up observation of SARS-CoV-2 positive patients with regard to the aspect of fatigue (cognitive / motor) and psychological disorders in the areas of anxiety, depression and somatization.
Detailed description
After informed consent is given, questionnaires will be obtained 6 months and 12 months after infection. For analyzing cognitive and motor fatigue, classified in mildly, moderately or severely fatigue the questionnaire will be calculated by The Fatigue Scale for Motor and Cognitive Functions (FSMC). And the occurrence of Major Depressive Disorder, other depressive Syndrome or Panic syndrome measured by Brief Patient Health Questionnaire. The FSC19-KN trial already included patients with positive test for SARS-CoV-2 by PCR and volunteers with negative SARS-CoV-2 antibody testing. Verification of exclusion criteria had been completed in the main trial FSC19-KN. After the informed consent to participation in the sub-study is given all inclusion modalities are fulfilled.
Interventions
OTHERFulfilling Questionaires
Fulfilling Questionaires PHQ-D (brief) and FSMC
Sponsors
Hegau-Bodensee-Klinikum Singen
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Inclusion criteria
Patient must meet ALL of the following criteria. 1. Participation in the FSC19-KN study 2. Consent to participate in the survey
Exclusion criteria
1\. Failure to give consent to the survey
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Presence of fatigue | 6 month after infection | Evaluate cognitive and motor fatigue classified in mildly, moderately or severely fatigue |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Occurrence of Major Depressive Disorder, other depressive Syndrome or Panic syndrome. | 6 month after infection | analyzed by PHQ-D (brief) |
Countries
Germany
Outcome results
None listed